LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Relative Growth Rate | Standard Error of the Mean for Relative Growth Rate |
|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Mitoxantrone | 10.0 | uM | LJP6 | 0.0754 | 0.0369 | -0.5397 | 0.1011 |
| SK-BR-3 | Mitoxantrone | 10.0 | uM | LJP5 | 0.0937 | 0.0431 | -0.5069 | 0.0874 |
| SK-BR-3 | LDN-193189 | 10.0 | uM | LJP5 | 0.1497 | 0.0149 | -0.4171 | 0.0861 |
| SK-BR-3 | AT-7519 | 10.0 | uM | LJP6 | 0.1512 | 0.0312 | -0.4144 | 0.0969 |
| SK-BR-3 | CGP60474 | 10.0 | uM | LJP6 | 0.1653 | 0.0190 | -0.3933 | 0.1036 |
| SK-BR-3 | Geldanamycin | 10.0 | uM | LJP5 | 0.1761 | 0.0205 | -0.3771 | 0.1129 |
| SK-BR-3 | Omipalisib | 10.0 | uM | LJP6 | 0.1786 | 0.0263 | -0.3736 | 0.1221 |
| SK-BR-3 | AZD 5438 | 10.0 | uM | LJP6 | 0.1793 | 0.0255 | -0.3712 | 0.1152 |
| SK-BR-3 | HG-6-64-01 | 10.0 | uM | LJP6 | 0.1828 | 0.0305 | -0.3573 | 0.0501 |
| SK-BR-3 | Geldanamycin | 10.0 | uM | LJP6 | 0.1901 | 0.0054 | -0.3491 | 0.0711 |
| SK-BR-3 | GSK1059615 | 10.0 | uM | LJP5 | 0.1923 | 0.0122 | -0.3484 | 0.0982 |
| SK-BR-3 | GSK1059615 | 10.0 | uM | LJP6 | 0.1916 | 0.0191 | -0.3465 | 0.0790 |
| SK-BR-3 | AT-7519 | 3.33 | uM | LJP6 | 0.1994 | 0.0334 | -0.3348 | 0.1013 |
| SK-BR-3 | CGP60474 | 3.33 | uM | LJP6 | 0.2040 | 0.0133 | -0.3270 | 0.0838 |
| SK-BR-3 | Alvocidib | 10.0 | uM | LJP6 | 0.2068 | 0.0247 | -0.3262 | 0.1168 |
| BT-20 | LDN-193189 | 10.0 | uM | LJP5 | 0.0950 | 0.0213 | -0.3104 | 0.0122 |
| BT-20 | A443654 | 10.0 | uM | LJP6 | 0.0977 | 0.0196 | -0.3087 | 0.0548 |
| SK-BR-3 | Mitoxantrone | 3.33 | uM | LJP6 | 0.2147 | 0.0398 | -0.3078 | 0.0957 |
| SK-BR-3 | SNS-032 | 10.0 | uM | LJP6 | 0.2180 | 0.0218 | -0.3078 | 0.1136 |
| MCF7 | Mitoxantrone | 10.0 | uM | LJP5 | 0.0585 | 0.0231 | -0.3076 | 0.0410 |
| MCF7 | Mitoxantrone | 10.0 | uM | LJP6 | 0.0587 | 0.0234 | -0.3075 | 0.0453 |
| SK-BR-3 | Alvocidib | 1.11 | uM | LJP6 | 0.2178 | 0.0297 | -0.3074 | 0.1167 |
| BT-20 | CGP60474 | 10.0 | uM | LJP6 | 0.1020 | 0.0161 | -0.3023 | 0.0492 |
| SK-BR-3 | CGP60474 | 10.0 | uM | LJP5 | 0.2228 | 0.0188 | -0.2992 | 0.1081 |
| SK-BR-3 | Alvocidib | 3.33 | uM | LJP6 | 0.2227 | 0.0380 | -0.2986 | 0.1210 |